Funding
← Back to your selection

European Investment Bank (EIB)

Activity from announced rounds

Activity in this selectionOct 18, 2026 · Jul 21, 2026
Rounds participated in
1
Confirmed lead rounds
0
All roles disclosed
New companies
1
First participation on record · 0 follow-on
Funding in participating rounds
$34.8M
1 disclosed · full round size, not this investor’s share

By stage

Undisclosed1

By primary sector

Biotech1

By country

Germany1

Rounds

1 in this selection
Ethris

Ethris develops inhaled mRNA therapeutics and vaccines for respiratory diseases, using proprietary RNA stabilization and nanoparticle delivery platforms.

€30MHERA Invest financing
Participant